Pfizer is striking a deal with Effector Therapeutics, a San Diego–based startup that’s developing small-molecule drugs to inhibit hyperactive translation in tumors. The big pharma firm will pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results